Test on Pulmonary Diseases: Diagnosis and Treatment
Pulmonary Diseases: Diagnosis & Treatment for Students
Test: Chronic Obstructive Pulmonary Disease Overview, Pulmonary Diagnostics, Chronic Obstructive Pulmonary Disease Management & Treatment, Asthma, Pulmonary Disease and Management, Interstitial and Fibrotic Lung Disease — Cystic & Bronchiectatic Disease, Lung Cancer Overview & Pathology, Lung Cancer Clinical Presentation & Syndromes, Lung Cancer Diagnosis & Management, Pleural and Air-leak Disorders, Interstitial and Fibrotic Lung Disease — General ILD, Interstitial and Fibrotic Lung Disease — Granulomatous ILD, Respiratory Failure: Diagnosis & Management, ARDS: Pathophysiology & Treatment, Pulmonary Vascular Disease - Pulmonary Hypertension, Pulmonary Vascular Disease - Pulmonary Embolism Diagnosis & Management
20 questions
Question 1: Stage I sarcoidosis on CXR is characterized by diffuse parenchymal infiltrates without hilar adenopathy.
A. Ano
B. Ne
Explanation: Stage I sarcoidosis on CXR is characterized by bilateral hilar adenopathy without parenchymal infiltrates. Diffuse parenchymal infiltrates without hilar adenopathy describe Stage III.
Question 2: According to the study materials, which of the following are typical pulmonary function test (PFT) results in a patient with sarcoidosis?
A. Decreased lung volumes (VC and TLC)
B. Decreased diffusing capacity for carbon monoxide (DL CO)
C. An increased FEV1/FVC ratio
D. Increased total lung capacity (TLC)
Explanation: PFTs in sarcoidosis typically show decreased lung volumes (VC and TLC), decreased diffusing capacity for carbon monoxide (DL CO), and a decreased or normal FEV1/FVC ratio. Options referring to increased FEV1/FVC ratio or increased TLC are incorrect.
Question 3: Arterial blood gas (ABG) analysis is considered a diagnostic imaging technique for respiratory failure.
A. Ano
B. Ne
Explanation: ABG analysis is a diagnostic tool, but CXR or CT scan of the chest are the diagnostic imaging techniques mentioned for respiratory failure.
Question 4: In patients with COPD who are experiencing hypercapnic respiratory failure, what can be a consequence of excessive oxygen administration?
A. Improved alveolar ventilation and CO2 elimination
B. The development of V/Q mismatch and the Haldane effect
C. A reduction in the alveolar–arterial oxygen difference
D. Prevention of hypoxemia without affecting hypercapnia
Explanation: According to the study materials, in COPD patients with hypercapnic respiratory failure, excessive administration of oxygen results in V/Q mismatch and the Haldane effect.
Question 5: During fluid management for ARDS, is a state of volume overload preferred for the patient?
A. Ano
B. Ne
Explanation: Volume overload should be avoided in ARDS fluid management. Instead, a low-normal intravascular volume is preferred, with the goal being a CVP of 4 to 6 cm H2O.